Loading clinical trials...
Loading clinical trials...
Clinical Study of Abandonment of Intravenous Volume Expansion After Preoperative Use of α-blockers in Patients With Adrenal Pheochromocytoma
Study of the relationship between hemodynamic stability and preoperative intravenous rehydration in patients with pheochromocytoma
All patients were subclassified into either the hemodynamic stability group (HS group) or the hemodynamic instability group (HU group) according to whether intraoperative hemodynamic instability occurred. Differences in data between the two groups were examined, and the risk factors for intraoperative hemodynamic instability were analyzed using logistic regression.
Age
18 - 85 years
Sex
ALL
Healthy Volunteers
No
Start Date
February 20, 2014
Primary Completion Date
October 20, 2022
Completion Date
October 20, 2022
Last Updated
April 7, 2023
95
ACTUAL participants
Abandonment of intravenous volume expansion during preoperative preparation in patients with pheochromocytoma
DRUG
Lead Sponsor
Kunwu Yan,MM
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions